Efficacy and Safety In Poorly Controlled Type 2 Diabetics

Clinical trial NCT00044460 · COMPLETED

Trial details

NCT number: NCT00044460
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2002-05-01
Primary completion: 2003-04-10
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.